1. Home
  2. NVEC vs ALT Comparison

NVEC vs ALT Comparison

Compare NVEC & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NVE Corporation

NVEC

NVE Corporation

HOLD

Current Price

$86.32

Market Cap

437.4M

Sector

Technology

ML Signal

HOLD

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$2.83

Market Cap

421.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVEC
ALT
Founded
1989
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
437.4M
421.5M
IPO Year
1995
2005

Fundamental Metrics

Financial Performance
Metric
NVEC
ALT
Price
$86.32
$2.83
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.67
AVG Volume (30 Days)
241.1K
4.6M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
5.13%
N/A
EPS Growth
0.96
25.37
EPS
3.14
N/A
Revenue
$26,331,218.00
$41,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$28.43
N/A
Revenue Growth
1.76
105.00
52 Week Low
$57.21
$2.56
52 Week High
$121.20
$6.44

Technical Indicators

Market Signals
Indicator
NVEC
ALT
Relative Strength Index (RSI) 39.42 43.42
Support Level $62.17 $2.62
Resistance Level $111.64 $3.15
Average True Range (ATR) 5.86 0.17
MACD -1.55 -0.02
Stochastic Oscillator 6.31 12.12

Price Performance

Historical Comparison
NVEC
ALT

About NVEC NVE Corporation

NVE Corp is engaged in developing and selling devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: